In life sciences, accuracy is not a differentiator — it’s a baseline requirement. Content errors don’t just damage reputation. They delay approvals, trigger regulatory queries, and in patient-facing materials, they can cause harm. The challenge for global enterprise is managing this at scale — across multiple languages, markets, regulatory environments and internal teams — without losing control of quality or timelines.